The Fragile X Syndrome is caused by transcriptional silencing of FMR1, the gene encoding the RNA binding protein FMRP. FMRP represses mRNA translation in the brain at the level of ribosome transit (polypeptide elongation). We have shown that Fragile X resuce occurs when FMRP knockout (KG) mice are subjected to genetic albation of the transational activator proiten CPEB, the signaling molecule p70S6 kinase 1 (S6K), or inhibiton of PI3 Kinase (PI3K). Moreover, protein synthesis levels, which are aberrantly high in the absence of FMRP, return to normal when CPEB, S6K1, or PI3K are ablated or inhibited. The RNAseq/bioinformatics (RB) core will provide computational analysis of newly developed genome-wide methods to investigate translational control and cytoplasmic polyadenylation in genetically-altered mice. The RB core will also serve as a data hub and standardize analysis for the three projects, and will provide an interface to sequencing facilities for the generation of cDNA libraries and deep sequencing. The RB core will assist the three research projects in data analysis and interpretation. The RB core has devised new computational methods to examine translation homeostasis in disease model mice and in human Fragile X iPS cells.

Public Health Relevance

The Fragile X Syndrome is the most common inherited for intellectual disability and the most prevalent monogenic form of autism. This RNAseq/bioinformatics core is a key part of this Center as it seeks to understand how translational homeostasis regulates the Fragile X syndrome. The Core will provide assistant, insight, and computational analysis assessing Fragile X model mice and human Fragile X IPS cells

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZHD1-DSR-Y (53))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Massachusetts Medical School Worcester
United States
Zip Code
Huynh, T N; Santini, E; Mojica, E et al. (2018) Activation of a novel p70 S6 kinase 1-dependent intracellular cascade in the basolateral nucleus of the amygdala is required for the acquisition of extinction memory. Mol Psychiatry 23:1394-1401
Liu, Botao; Li, Yue; Stackpole, Emily E et al. (2018) Regulatory discrimination of mRNAs by FMRP controls mouse adult neural stem cell differentiation. Proc Natl Acad Sci U S A 115:E11397-E11405
Santini, Emanuela; Huynh, Thu N; Longo, Francesco et al. (2017) Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice. Sci Signal 10:
Gao, Fen-Biao; Richter, Joel D; Cleveland, Don W (2017) Rethinking Unconventional Translation in Neurodegeneration. Cell 171:994-1000
Bhattacharya, Aditi; Mamcarz, Maggie; Mullins, Caitlin et al. (2016) Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice. Neuropsychopharmacology 41:1991-2000
Richter, Joel D; Bassell, Gary J; Klann, Eric (2015) Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci 16:595-605
Huynh, Thu N; Shah, Manan; Koo, So Yeon et al. (2015) eIF4E/Fmr1 double mutant mice display cognitive impairment in addition to ASD-like behaviors. Neurobiol Dis 83:67-74
Gross, Christina; Hoffmann, Anne; Bassell, Gary J et al. (2015) Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back. Neurotherapeutics 12:584-608
Richter, Joel D; Coller, Jeff (2015) Pausing on Polyribosomes: Make Way for Elongation in Translational Control. Cell 163:292-300